Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Zevalin (ibritumomab tiuxetan)
i
Other names:
IDEC-129, SHL-749, IDEC-Y2B8, SH-L749, SH-L-749, IDEC129, IDECY2B8, BAY86-5128, BAY86 5128, BAY865128, IDEC 129, IDEC Y2B8
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Assertio, Aurobindo, CASI, Mundipharma, Servier
Drug class:
CD20 inhibitor, Beta radiation emitter
Related drugs:
‹
rituximab (176)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
IMM0306 (2)
IGM-2323 (2)
mosunetuzumab-axgb (2)
AR160 (2)
rituximab-arrx (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
AcellBia (rituximab biosimilar) (0)
ACTR087 (0)
ALETA-001 (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
obinutuzumab-β (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CND261 (0)
DI Leu16 IL-2 (0)
IGN002 (0)
F007 (rituximab biosimilar) (0)
GB241 (rituximab biosimilar) (0)
GSK5926371 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
AME-133v (0)
ocrelizumab (0)
XmAb13676 (0)
PRO131921 (0)
PRO-203 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
TG20 (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
177Lu-lilotomab satetraxetan (4)
lutetium Lu 177 vipivotide tetraxetan (4)
CLR 131 (2)
lutetium Lu 177 dotatate (2)
AAA614 (2)
PNT2002 (2)
I-131-apamistamab (1)
CYT 500 (0)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-EBTATE (0)
[177Lu]FAPI-46 (0)
177Lu-HER3 ARC (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177 Lu-FC705 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
TLX591 (0)
TLX66 (0)
90Y-NM600 (0)
90Y-PPMX-T002 (0)
AAA603 (0)
Iomab-ACT (0)
iobenguane I 131 (0)
iodine I 131 tositumomab (0)
CAM-H2 (0)
Cu-67 SAR-Bombesin (0)
samarium-153 DOTMP (0)
ITM-91 (0)
Iodine-131-labeled metuximab (0)
ITM-31 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
131I-omburtamab (0)
rhenium Re186 obisbemeda (0)
67Cu MeCOSar octreotate (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
lutetium-177 DOTA satoreotide (0)
yttrium 90 microspheres (0)
Re (0)
OTSA101-DTPA-90Y (0)
rituximab (176)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
IMM0306 (2)
IGM-2323 (2)
mosunetuzumab-axgb (2)
AR160 (2)
rituximab-arrx (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
AcellBia (rituximab biosimilar) (0)
ACTR087 (0)
ALETA-001 (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
obinutuzumab-β (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CND261 (0)
DI Leu16 IL-2 (0)
IGN002 (0)
(0)
GB241 (rituximab biosimilar) (0)
GSK5926371 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
AME-133v (0)
ocrelizumab (0)
XmAb13676 (0)
PRO131921 (0)
PRO-203 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
TG20 (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
177Lu-lilotomab satetraxetan (4)
lutetium Lu 177 vipivotide tetraxetan (4)
CLR 131 (2)
lutetium Lu 177 dotatate (2)
AAA614 (2)
PNT2002 (2)
I-131-apamistamab (1)
CYT 500 (0)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-EBTATE (0)
[177Lu]FAPI-46 (0)
177Lu-HER3 ARC (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177 Lu-FC705 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
TLX591 (0)
TLX66 (0)
90Y-NM600 (0)
90Y-PPMX-T002 (0)
AAA603 (0)
Iomab-ACT (0)
iobenguane I 131 (0)
iodine I 131 tositumomab (0)
CAM-H2 (0)
Cu-67 SAR-Bombesin (0)
samarium-153 DOTMP (0)
ITM-91 (0)
Iodine-131-labeled metuximab (0)
ITM-31 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
131I-omburtamab (0)
rhenium Re186 obisbemeda (0)
67Cu MeCOSar octreotate (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
lutetium-177 DOTA satoreotide (0)
yttrium 90 microspheres (0)
Re (0)
OTSA101-DTPA-90Y (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
CD20 positive
Follicular Lymphoma
CD20 positive
Follicular Lymphoma
rituximab + ibritumomab tiuxetan
Sensitive: A1 - Approval
rituximab + ibritumomab tiuxetan
Sensitive
:
A1
rituximab + ibritumomab tiuxetan
Sensitive: A1 - Approval
rituximab + ibritumomab tiuxetan
Sensitive
:
A1
No biomarker
Follicular Lymphoma
No biomarker
Follicular Lymphoma
ibritumomab tiuxetan
Sensitive: A1 - Approval
ibritumomab tiuxetan
Sensitive
:
A1
ibritumomab tiuxetan
Sensitive: A1 - Approval
ibritumomab tiuxetan
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
No biomarker
Marginal Zone Lymphoma
ibritumomab tiuxetan
Sensitive: A2 - Guideline
ibritumomab tiuxetan
Sensitive
:
A2
ibritumomab tiuxetan
Sensitive: A2 - Guideline
ibritumomab tiuxetan
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.